Table 1 The clinical characteristic of participants according to the trajectories of NLR.
NLR (%) | P | |||
|---|---|---|---|---|
Low level NLR | Moderate level NLR | High level NLR | ||
n | 281 | 629 | 212 | |
Sex (male) | 103(36.5%) | 251(39.9%) | 97(45.8%) | 0.115 |
BMI (kg/m2) | 23.86 ± 3.14 | 23.91 ± 3.02 | 23.78 ± 3.16 | 0.933 |
Age (years) | 47.79 ± 10.51 | 47.55 ± 10.10 | 48.02 ± 11.60 | 0.284 |
WBC (× 109/L) | 5.63 ± 1.42 | 6.07 ± 1.47 | 6.36 ± 1.61 | < 0.001 |
RBC (× 1012/L) | 4.63 ± 0.43 | 4.67 ± 0.45 | 4.69 ± 0.48 | 0.473 |
HBG (g/L) | 137.17 ± 15.08 | 137.79 ± 15.10 | 138.65 ± 14.98 | 0.558 |
HCT (%) | 41.45 ± 3.96 | 41.94 ± 4.36 | 41.61 ± 4.02 | 0.68 |
PLT (× 109/L) | 215.17 ± 43.80 | 209.18 ± 46.49 | 212.48 ± 43.91 | 0.363 |
AST (U/L) | 17.00(15.00 ~ 21.00) | 17.00(15.00 ~ 20.00) | 17.00(14.00 ~ 19.00) | 0.011 |
ALT (U/L) | 17.00(12.00 ~ 23.00) | 16.00(12.00 ~ 23.00) | 16.00(12.00 ~ 22.00) | 0.656 |
Neutrophil (× 109/L) | 2.69 ± 0.73 | 3.60 ± 1.05 | 4.18 ± 1.32 | < 0.001 |
Lymphocyte (× 109/L) | 2.43 ± 0.62 | 2.14 ± 0.48 | 1.96 ± 0.46 | < 0.001 |
TP (g/L) | 76.27 ± 4.33 | 75.70 ± 4.21 | 75.45 ± 4.15 | 0.039 |
ALB (g/L) | 45.58 ± 1.95 | 45.58 ± 1.83 | 45.51 ± 1.51 | 0.218 |
GGT (umol/L) | 20.00(14.00 ~ 29.00) | 21.00(14.00 ~ 34.50) | 18.00(14.00 ~ 26.00) | 0.047 |
FPG (mmol/L) | 5.17 ± 0.65 | 5.36 ± 1.23 | 5.37 ± 1.10 | 0.037 |
TC (mmol/L) | 4.98 ± 0.78 | 4.94 ± 0.90 | 4.79 ± 0.81 | 0.031 |
TG (mmol/L) | 1.17(0.81 ~ 1.69) | 1.17(0.80 ~ 1.92) | 1.19(0.80 ~ 1.79) | 0.845 |
HDL (mmol/L) | 1.52 ± 0.38 | 1.49 ± 0.38 | 1.45 ± 0.36 | 0.181 |
LDL (mmol/L) | 3.04 ± 0.68 | 2.97 ± 0.78 | 2.89 ± 0.69 | 0.152 |
SBP (mmHg) | 123.39 ± 16.30 | 124.04 ± 16.20 | 122.88 ± 16.80 | 0.776 |
DBP (mmHg) | 78.52 ± 10.11 | 79.31 ± 10.62 | 77.43 ± 9.73 | 0.127 |
Smoking | ||||
Yes | 56(19.9%) | 174(27.7%) | 69(32.6%) | 0.005 |
No | 225(80.1%) | 455(72.3%) | 143(67.4%) | |
Drinking | ||||
Yes | 97(34.5%) | 219(34.8%) | 76(35.8%) | 0.935 |
No | 184(65.5%) | 410(65.2%) | 135(64.2%) | |